Evidence map›Paper›PMID 31291191›Full record

ArticleeLife2019

Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism.

Samuel Andrew Malone, Georgios E Papadakis, Andrea Messina, Nour El Houda Mimouni, Sara Trova, Monica Imbernon, Cecile Allet, Irene Cimino, James Acierno, Daniele Cassatella and 10 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Clinical Utility of Anti-Mullerian Hormone in Pediatrics.The Journal of clinical endocrinology and metabolism · 2022
    Pooled it
  4. Genetics of Idiopathic Hypogonadotropic HypogonadismJournal of clinical research in pediatric endocrinology · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Genetic insights into the complexity of premature ovarian insufficiency.Reproductive biology and endocrinology : RB&E · 2024
    Review
  16. Article
  17. Puberty Blocker and Aging Impact on Testicular Cell States and Function.bioRxiv : the preprint server for biology · 2024
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 4 countries.

Samuel Andrew MaloneJean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.ORCID 0000-0002-6824-6854
Georgios E PapadakisFaculty of Biology and Medicine, Service of Endocrinology, Diabetology and Metabolism, University Hospital, Lausanne, Switzerland.
Andrea MessinaFaculty of Biology and Medicine, Service of Endocrinology, Diabetology and Metabolism, University Hospital, Lausanne, Switzerland.
Nour El Houda MimouniJean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.
Sara TrovaJean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.
Monica ImbernonJean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.
Cecile AlletJean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.
Irene CiminoJean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.
James AciernoFaculty of Biology and Medicine, Service of Endocrinology, Diabetology and Metabolism, University Hospital, Lausanne, Switzerland.
Daniele CassatellaFaculty of Biology and Medicine, Service of Endocrinology, Diabetology and Metabolism, University Hospital, Lausanne, Switzerland.
Cheng XuFaculty of Biology and Medicine, Service of Endocrinology, Diabetology and Metabolism, University Hospital, Lausanne, Switzerland.
Richard QuintonInstitute of Genetic Medicine, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, United Kingdom.
Gabor SzinnaiPediatric Endocrinology and Diabetology, University of Basel Children's Hospital, Basel, Switzerland.
Pascal PignyCHU Lille, Laboratoire de Biochimie et Hormonologie, Centre de Biologie Pathologie, Lille, France.
Lur Alonso-CotchicoDepartament de Química, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Laura MasgrauDepartament de Química, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Jean-Didier MaréchalDepartament de Química, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Vincent PrevotJean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.ORCID 0000-0001-7185-3615
Nelly PitteloudFaculty of Biology and Medicine, Service of Endocrinology, Diabetology and Metabolism, University Hospital, Lausanne, Switzerland.
Paolo GiacobiniJean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm, UMR-S 1172, Lille, France.ORCID 0000-0002-3075-1441
Inserm · FRUniversitat Autònoma de Barcelona · ESCentre Hospitalier Universitaire de Lille · FRNewcastle University · GBUniversity of Basel · CH

Funding

Agence Nationale de la Recherche ANR-14-CE12-0015-01Generalitat de Catalunya 2017SGR1323Horizon 2020 Framework Programme ERC-2016-CoG 725149Horizon 2020 Framework Programme H2020-MSCA-IF-2017Ministerio de Ciencia e Innovación CTQ2017-83745-PMinisterio de Ciencia e Innovación CTQ2017-87889-P
6 · The paper itself

Abstract

Congenital hypogonadotropic hypogonadism (CHH) is a condition characterized by absent puberty and infertility due to gonadotropin releasing hormone (GnRH) deficiency, which is often associated with anosmia (Kallmann syndrome, KS). We identified loss-of-function heterozygous mutations in anti-Müllerian hormone (

Indexed as

Signal TransductionAdolescentAdultAmino Acid SequenceAnimalsAnti-Mullerian HormoneAxonsBone Morphogenetic Protein Receptors, Type ICell MovementChlorocebus aethiopsCOS CellsFemaleFertilityFetusGonadotropin-Releasing HormoneHeterozygoteAmhr2 protein, mouseAnti-Mullerian HormoneBone Morphogenetic Protein Receptors, Type IGonadotropin-Releasing HormoneLuteinizing HormoneReceptors, Transforming Growth Factor betaAMHcell migrationdevelopmental biologygeneticsgenomicsGnRHhumanKallmann's syndromemousereproduction

Identifiers

PMID31291191
PMCPMC6620045
OpenAlexW2957943262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.